Bayview Pharmacy's Erythromycin 3%/Hydrocortisone 2% Topical Gel is a semisolid formulation dispensed through a pump mechanism. This design allows for easy and precise application on the skin, facilitating targeted treatment or absorption of active ingredients.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Bayview Pharmacy's Erythromycin 3%/Hydrocortisone 2% Topical Gel is a specially compounded medication designed to address a range of skin conditions. This unique formulation combines the antibacterial properties of erythromycin with the anti-inflammatory and itch-relieving benefits of hydrocortisone. Together, these active ingredients work synergistically to combat skin conditions such as acne, eczema, psoriasis, and rosacea.
The Erythromycin 3%/Hydrocortisone 2% Topical Gel is a semisolid formulation that is dispensed through a pump mechanism. This design facilitates easy and precise application on the skin, ensuring targeted treatment and optimal absorption of the active ingredients. The gel-like consistency of the medication allows for smooth application and rapid absorption, enhancing the efficacy of the treatment.
Application of the Erythromycin 3%/Hydrocortisone 2% Topical Gel can be done up to four times a day, or as directed by your healthcare provider. It is crucial to adhere to the instructions provided by your healthcare provider to ensure the best possible results. Please be aware that this medication should not be applied to broken or infected skin.
If you have any queries or concerns about the Erythromycin 3%/Hydrocortisone 2% Topical Gel or any other compounded medications, please do not hesitate to contact us at Bayview Pharmacy. Our team of compounding pharmacists is equipped with the knowledge and expertise to assist you. We are committed to providing you with the highest quality of care and service.
Erythromycin 3%/Hydrocortisone 2% Topical Gel is a compounded formulation designed for the treatment of mild to moderate inflammatory and pruritic dermatoses in both adults and children. This semisolid formulation is dispensed through a pump mechanism, allowing for easy and precise application on the skin. The gel-like consistency ensures targeted treatment or absorption of the active ingredients.
It is important to note that this formulation is not recommended for patients with known hypersensitivity to any of the components of the formulation. Additionally, it is not advised for use in patients with rosacea, perioral dermatitis, or acne vulgaris. Patients should be instructed to avoid contact with the eyes and to wash their hands after application. It is also recommended that patients use the product for the shortest duration necessary to achieve the desired therapeutic effect.
Erythromycin 3%/Hydrocortisone 2% Topical Gel has demonstrated effectiveness in the treatment of atopic dermatitis, contact dermatitis, seborrheic dermatitis, and psoriasis.
Caution should be exercised when using Erythromycin 3%/Hydrocortisone 2% Topical Gel in patients with a history of systemic corticosteroid use, as it may increase the risk of systemic side effects. It should also be used with caution in patients with a history of hypersensitivity to macrolide antibiotics.
If you have any questions about the use of Erythromycin 3%/Hydrocortisone 2% Topical Gel, please do not hesitate to reach out for further information.
Erythromycin 3%/Hydrocortisone 2% Topical Gel is a compounded formulation designed to treat a variety of skin conditions. This unique combination medication brings together the antibacterial properties of erythromycin and the anti-inflammatory and itch-relieving benefits of hydrocortisone. Erythromycin is an antibiotic that works by eliminating bacteria responsible for causing infections. On the other hand, hydrocortisone is a corticosteroid that effectively reduces inflammation and itching.
This topical gel is particularly useful in treating bacterial skin infections such as impetigo, folliculitis, and infected eczema. It is also beneficial in managing contact dermatitis, a type of skin rash that occurs due to contact with an allergen or irritant.
The Erythromycin 3%/Hydrocortisone 2% Topical Gel is designed for direct application on the affected skin area. It is typically recommended to be applied two to four times a day, or as directed by a healthcare professional. It is crucial to clean your hands before and after applying the medication to prevent further infection. It is also advised to avoid contact with the eyes, nose, and mouth, and not to apply the gel on broken or irritated skin.
Discontinuing the medication prematurely, even if symptoms seem to improve, may result in the infection not being completely cured. If you have any queries about the usage of this medication, it is recommended to consult with a healthcare professional.
This compounded formulation of Erythromycin 3%/Hydrocortisone 2% Topical Gel is a versatile treatment option for a variety of skin conditions. It is a semisolid formulation dispensed through a pump mechanism, which allows for easy and precise application on the skin. The gel-like consistency ensures targeted treatment or absorption of the active ingredients.
The formulation is also beneficial in reducing the appearance of scars and stretch marks, making it a valuable addition to your skincare routine.
Furthermore, this formulation can be used to minimize the appearance of wrinkles and fine lines, age spots, and other skin discolorations. It is also beneficial in treating skin damage caused by UV exposure, including sunburns. The Erythromycin 3%/Hydrocortisone 2% Topical Gel can also be used to reduce the appearance of acne scars and other blemishes, promoting a clearer and healthier complexion.
If you have any questions about the use of this formulation, please do not hesitate to reach out. We are here to provide you with the information you need to make an informed decision about your skincare treatment options.
This is a compounded formulation that combines Erythromycin, an antibiotic, and Hydrocortisone, a corticosteroid. It is designed to treat a variety of skin conditions by reducing inflammation and fighting bacteria.
This formulation is dispensed through a pump mechanism. This allows for easy and precise application on the skin.
The Erythromycin 3%/Hydrocortisone 2% Topical Gel has a gel-like consistency. This makes it easy to apply and absorb into the skin.
You should apply this gel to the affected area as directed by your healthcare provider. The pump mechanism allows for targeted treatment.
No, this gel is specifically formulated to treat certain skin conditions. It is important to consult with your healthcare provider to determine if this is the right treatment for your condition.
The active ingredients in this gel are Erythromycin, which is an antibiotic, and Hydrocortisone, which is a corticosteroid.
Erythromycin is an antibiotic that fights bacteria on the skin. It helps to reduce the presence of bacteria that may contribute to the skin condition.
Hydrocortisone is a corticosteroid that reduces inflammation. This can help to alleviate symptoms such as redness, itching, and swelling associated with certain skin conditions.
If you have sensitive skin, it is important to consult with your healthcare provider before using this gel. They can provide guidance based on your specific skin type and condition.
If you experience any side effects, such as increased redness, itching, or swelling, you should stop using the gel and contact your healthcare provider immediately.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)